p34
cdc2 protein directly regulating the cell cycle in 63 patients suffering from tongue squamous cell carcinomas (SCCs) was investigated by the immunohistochemical method. p34
cdc2 was detected in 34 of 63 tumors (54.0%) using a staining method. The average incidence of p34
cdc2 positive cells was 17.7%. A distributive tendency of p34
cdc2 protein, which was expressed in the periphery of the cancer cell nest and scattered over the diffuse infiltrating cancer, was found.
The research on the relation between the expression of p34
cdc2 and the factor T suggested that positive staining of p34
cdc2 was shown in 4 of 11 cases (36.4%) of T1 tumor, 22 of 37 cases (59.5%) of T2 tumor, and 4 of 5 cases (80.0%) of T3 tumor, and showed an increasing tendency of p34
cdc2 incidence from T1 tumor to T3 tumor, but showed a low incidence in 4 of 10 cases (40.0%) of T4 tumor. The investigation on the relation between the expression of p34
cdc2 and factor N showed that p34
cdc2 was in 14 of 32 cases (43.8%) of N0 tumor, 19 of 25 cases (76.0%) of N1 tumor and 1 of 6 cases (16.7%) of N2 tumor, which was fewer. The survey of the relation between the expression of p34
cdc2 and tumor stage also showed an increasing expression of p34
cdc2 corresponding with the increasing stage of the tumor from stage I to stage III, but a decreased expression of p34
cdc2 appeared in stage IV. Namely, it suggested that the cell proliferating activity increased corresponding with the clinical progression of the tumor, however, the activity decreased in the most advanced tumor. The observation of the relation between the expression of p34
cdc2 and histopathologic findings showed that higher incidence of p34
cdc2 was found in 5 of 5 cases (100%) in WHO Grade III tumor, 10 of 15 cases (66.7%) in 4C and 4D invasive tumor, 13 of 17 cases (76.5%) in severe cellular atypia tumor. Namely, there was a correlation between the expression of p34
cdc2 and the histologic malignancy of tumor.
The results suggested that the detection of p34
cdc2 expression was beneficial for elucidating the nature of tumor malignancy of tongue squamous cell carcinoma.
View full abstract